Lacramioara Spetie1, L Eugene Arnold. 1. Department of Psychiatry, Ohio State University, 1670 Upham Drive, Columbus, OH 43210, USA. Lacramioara.Spetie@osumc.edu
Abstract
INTRODUCTION: Psychoactive drug prescription for preschoolers has increased over the past decade and has been a controversial topic for those who prescribe, regulate, and research the use of psychotropics in this population. Children and adolescents are deemed vulnerable populations, at risk of being harmed by unethical or suboptimal practice and research and are in need of special protection. Historically, preschoolers have been therapeutic and research "orphans," excluded from pharmacological studies so that the evidence base for their treatment has to be extrapolated from other ages. Within the past few decades, several ethical principles guiding pediatric psychopharmacological research have been developed. The same principles could effectively guide the treatment of these patients. CONCLUSION: Further studies are needed to elucidate the safety and effectiveness of psychotropics, and sound ethical guidelines for their involvement in psychiatric research are needed. This article reviews some challenges facing mental health care providers involved in prescribing or researching the use of psychoactive drugs in preschoolers. Some of these challenges are general to medical treatment and research with children, and others are particular to child psychopharmacological treatment and research.
INTRODUCTION: Psychoactive drug prescription for preschoolers has increased over the past decade and has been a controversial topic for those who prescribe, regulate, and research the use of psychotropics in this population. Children and adolescents are deemed vulnerable populations, at risk of being harmed by unethical or suboptimal practice and research and are in need of special protection. Historically, preschoolers have been therapeutic and research "orphans," excluded from pharmacological studies so that the evidence base for their treatment has to be extrapolated from other ages. Within the past few decades, several ethical principles guiding pediatric psychopharmacological research have been developed. The same principles could effectively guide the treatment of these patients. CONCLUSION: Further studies are needed to elucidate the safety and effectiveness of psychotropics, and sound ethical guidelines for their involvement in psychiatric research are needed. This article reviews some challenges facing mental health care providers involved in prescribing or researching the use of psychoactive drugs in preschoolers. Some of these challenges are general to medical treatment and research with children, and others are particular to child psychopharmacological treatment and research.
Authors: Normand J Carrey; Serdar Dursun; Robert Clements; Ken Renton; Dan Waschbusch; Frank P MacMaster Journal: J Am Acad Child Adolesc Psychiatry Date: 2002-08 Impact factor: 8.829
Authors: Laurence L Greenhill; Peter S Jensen; Howard Abikoff; Jeffery L Blumer; Joseph Deveaugh-Geiss; Celia Fisher; Kimberly Hoagwood; Christopher J Kratochvil; Benjamin B Lahey; Thomas Laughren; James Leckman; Theodore A Petti; Kayla Pope; David Shaffer; Beneditto Vitiello; Charles Zeanah Journal: J Am Acad Child Adolesc Psychiatry Date: 2003-04 Impact factor: 8.829
Authors: Christina D Chambers; Sonia Hernandez-Diaz; Linda J Van Marter; Martha M Werler; Carol Louik; Kenneth Lyons Jones; Allen A Mitchell Journal: N Engl J Med Date: 2006-02-09 Impact factor: 91.245
Authors: April V P Clyburne-Sherin; Pravheen Thurairajah; Mufiza Z Kapadia; Margaret Sampson; Winnie W Y Chan; Martin Offringa Journal: Trials Date: 2015-09-18 Impact factor: 2.279
Authors: Guillermo Perez Algorta; Heather A MacPherson; L Eugene Arnold; Stephen P Hinshaw; Lily Hechtman; Margaret H Sibley; Elizabeth B Owens Journal: Eur Child Adolesc Psychiatry Date: 2019-12-20 Impact factor: 4.785